findmyKOL

Tulio Bertorini, MD

Enriched profile

Semmes Murphy Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Memphis, TN · Southeast · United StatesSpecialtyNeurologyFocusPeripheral Neuropathies and Disorders+4
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH funding1995–1998Why? →

Tulio Bertorini is a Peripheral Neuropathies and Disorders physician affiliated with Semmes Murphy Clinic. OpenAlex indexes 278 publications with 5,642 citations (h-index 34); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 24 Oct 2026

Tulio Bertorini, MD, is affiliated with Semmes Murphy Clinic. The public record shows 278 publications with 5,642 citations (h-index 34), centered on Peripheral Neuropathies and Disorders, Muscle Physiology and Disorders, Peripheral Nerve Disorders. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 40 companies, 1 NIH-funded awards (1995–1998).

  • Top research focus: Peripheral Neuropathies and Disorders
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 40 companies

Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Pain1 trialDiabetic Neuropathies1 trialParesthesia1 trial

Research focus

OpenAlex concept fingerprint
Peripheral Neuropathies and DisordersMuscle Physiology and DisordersPeripheral Nerve DisordersMedical Case Reports and StudiesInflammatory Myopathies and Dermatomyositis

Drugs & molecules

across trials, industry payments and publications
Zilbrysqgeneric · ZilucoplanClinical trials—Industry payments15Publications1Solirisgeneric · EculizumabClinical trials—Industry payments8Publications3Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments49Publications—Ubrelvygeneric · UbrogepantClinical trials—Industry payments28Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments27Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments25Publications—Kesimptageneric · OfatumumabClinical trials—Industry payments14Publications—Quliptageneric · AtogepantClinical trials—Industry payments14Publications—RimegepantClinical trials—Industry payments13Publications—Rystiggogeneric · RozanolixizumabClinical trials—Industry payments13Publications—Bafiertamgeneric · Monomethyl fumarateClinical trials—Industry payments12Publications—Aimoviggeneric · ErenumabClinical trials—Industry payments11Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments71Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments38Argenx Us, Inc.Clinical trials—Industry payments32UCB, Inc.Clinical trials—Industry payments31Novartis Pharmaceuticals CorporationClinical trials—Industry payments18Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments14Banner Life Sciences, LLCClinical trials—Industry payments12Allergan, Inc.Clinical trials—Industry payments11Amgen Inc.Clinical trials—Industry payments10Biohaven Pharmaceuticals, Inc.Clinical trials—Industry payments10Celgene CorporationClinical trials—Industry payments8Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments8EMD Serono, Inc.Clinical trials—Industry payments6Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments5Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments5Genzyme CorporationClinical trials—Industry payments4Horizon Therapeutics plcClinical trials—Industry payments4Pfizer Inc.Clinical trials—Industry payments4SK Life Science, Inc.Clinical trials—Industry payments4ACADIA Pharmaceuticals IncClinical trials—Industry payments3Avanir Pharmaceuticals, Inc.Clinical trials—Industry payments3Biogen, Inc.Clinical trials—Industry payments3CSL BehringClinical trials—Industry payments3Genentech USA, Inc.Clinical trials—Industry payments3GRT US Holding, Inc.Clinical trials—Industry payments3Lilly USA, LLCClinical trials—Industry payments3Amneal Pharmaceuticals LLCClinical trials—Industry payments2Adamas Pharmaceuticals, Inc.Clinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Biohaven Pharmaceutical Holding Company Ltd.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
278publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

5,642citations

Total citations across indexed works.

34h-index

Hirsch index (OpenAlex). i10-index 77.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
40companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1995–1998

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Medical Director

    ALS Association Midsouth clinic (Wesley Neurology Clinic, 6325 Humphreys Blvd, Memphis, TN)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →als.org ↗

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 24 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 24 Oct 2026

40 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 24 Oct 2026

1 NIH research award on record, funded 1995–1998 per NIH RePORTER. The latest:

Publications

Network

Updated 24 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Richard Bedlack20Paul J Wicks19Gary L. Pattee19Christopher J. McDermott18Dylan Ratner16Paul E. Barkhaus16Mark B. Bromberg15Sartaj Jhooty14Mazen M. Dimachkie14Michael G Benatar13Javier Mascías Cadavid13Genaro M. A. Palmieri13Jesse Ian Crayle12Gregory T. Carter12Terry D Heiman-Patterson11Andrew D. Brown11Pushpa Narayanaswami10Carlayne E. Jackson10Carmel Armon10Masanori Igarashi9Robert P. Bowser9Morgan T Beauchamp9LINDA H. HORNER8Nicholas J. Silvestri8Michael Pulley8Tahseen Mozaffar8Tuan Vu7Carolina Tesi Rocha7Waqar Waheed7Erik Henricson7J. Howard Jaster7Namita Goyal7Eva L. Feldman7Anneke J. van der Kooi7Thomas Harbo7Giovanni Antonini7Paula R. Clemens7Anne M. Connolly7Yuyao Sun7Ksenija Gorni7

Online presence

Updated 24 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/tulio-bertorini-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 24 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uthsc.edu ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.